Literature DB >> 23311122

Elevated nocturnal desaturation index predicts mortality in interstitial lung disease.

T J Corte1, S J Wort, S Talbot, P M Macdonald, D M Hansel, M Polkey, E Renzoni, T M Maher, A G Nicholson, A U Wells.   

Abstract

BACKGROUND: Nocturnal desaturation may contribute to long-term pulmonary vascular stress in interstitial lung disease (ILD). We study the prevalence, severity and prognostic utility of nocturnal desaturation across ILD.
METHODS: ILD patients with overnight oximetry (June 2006-August 2008) were reviewed (n = 134). Significant nocturnal desaturation was considered as > 10% of sleep with SpO2 < 90%. Desaturation index (DI) was defined as the number of desaturation events > 4%/hr. Covariates, including indices of nocturnal desaturation, were evaluated against mortality.
RESULTS: Nocturnal desaturation was present in 49 (37%) patients. 31% of patients had pulmonary hypertension (PH) on echocardiography. Increased DI was associated with higher mortality independent of age, gender and BMI (HR 1.04; 95% CI 1.00, 1.06; p = 0.009). In separate models, DI and a) elevated brain natriuretic peptide (BNP; HR 1.04; 95% CI 1.00, 1.08; p = 0.04); b) moderate-severe PH on echocardiography (HR 3.15; 95% CI 1.24, 8.00; p = 0.02); and c) daytime resting SpO2 (HR 0.92; 95% CI 0.85, 0.99; p = 0.04) independently predicted mortality following adjustment for age, gender and BMI.
CONCLUSION: Nocturnal desaturation is common and may be severe in ILD. Elevated nocturnal DI predicts higher mortality across ILD, independent of other vascular parameters. This finding may have important implications for the pathogenesis of PH in IPF.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23311122

Source DB:  PubMed          Journal:  Sarcoidosis Vasc Diffuse Lung Dis        ISSN: 1124-0490            Impact factor:   0.670


  13 in total

1.  Sleep oxygen desaturation predicts survival in idiopathic pulmonary fibrosis.

Authors:  Likurgos Kolilekas; Effrosyni Manali; Katerina A Vlami; Panagiotis Lyberopoulos; Christina Triantafillidou; Konstantinos Kagouridis; Katerina Baou; Sotirios Gyftopoulos; Konstantinos N Vougas; Anna Karakatsani; Manos Alchanatis; Spyros Papiris
Journal:  J Clin Sleep Med       Date:  2013-06-15       Impact factor: 4.062

2.  Sequencing Analysis at 8p23 Identifies Multiple Rare Variants in DLC1 Associated with Sleep-Related Oxyhemoglobin Saturation Level.

Authors:  Jingjing Liang; Brian E Cade; Karen Y He; Heming Wang; Jiwon Lee; Tamar Sofer; Stephanie Williams; Ruitong Li; Han Chen; Daniel J Gottlieb; Daniel S Evans; Xiuqing Guo; Sina A Gharib; Lauren Hale; David R Hillman; Pamela L Lutsey; Sutapa Mukherjee; Heather M Ochs-Balcom; Lyle J Palmer; Jessica Rhodes; Shaun Purcell; Sanjay R Patel; Richa Saxena; Katie L Stone; Weihong Tang; Gregory J Tranah; Eric Boerwinkle; Xihong Lin; Yongmei Liu; Bruce M Psaty; Ramachandran S Vasan; Michael H Cho; Ani Manichaikul; Edwin K Silverman; R Graham Barr; Stephen S Rich; Jerome I Rotter; James G Wilson; Susan Redline; Xiaofeng Zhu
Journal:  Am J Hum Genet       Date:  2019-10-24       Impact factor: 11.025

Review 3.  Sleep disordered breathing in interstitial lung disease: A review.

Authors:  Lauren K Troy; Tamera J Corte
Journal:  World J Clin Cases       Date:  2014-12-16       Impact factor: 1.337

4.  OSA and Prolonged Oxygen Desaturation During Sleep are Strong Predictors of Poor Outcome in IPF.

Authors:  Marcello Bosi; Giulia Milioli; Francesco Fanfulla; Sara Tomassetti; Jay H Ryu; Liborio Parrino; Silvia Riccardi; Andrea Melpignano; Anna Elisabetta Vaudano; Claudia Ravaglia; Paola Tantalocco; Andrea Rossi; Venerino Poletti
Journal:  Lung       Date:  2017-07-03       Impact factor: 2.584

5.  Pulmonary Overlap Syndromes, with a focus on COPD and ILD.

Authors:  Katherine A Dudley; Atul Malhotra; Robert L Owens
Journal:  Sleep Med Clin       Date:  2014-09

6.  Associations of variants In the hexokinase 1 and interleukin 18 receptor regions with oxyhemoglobin saturation during sleep.

Authors:  Brian E Cade; Han Chen; Adrienne M Stilp; Tin Louie; Sonia Ancoli-Israel; Raanan Arens; Richard Barfield; Jennifer E Below; Jianwen Cai; Matthew P Conomos; Daniel S Evans; Alexis C Frazier-Wood; Sina A Gharib; Kevin J Gleason; Daniel J Gottlieb; David R Hillman; W Craig Johnson; David J Lederer; Jiwon Lee; Jose S Loredo; Hao Mei; Sutapa Mukherjee; Sanjay R Patel; Wendy S Post; Shaun M Purcell; Alberto R Ramos; Kathryn J Reid; Ken Rice; Neomi A Shah; Tamar Sofer; Kent D Taylor; Timothy A Thornton; Heming Wang; Kristine Yaffe; Phyllis C Zee; Craig L Hanis; Lyle J Palmer; Jerome I Rotter; Katie L Stone; Gregory J Tranah; James G Wilson; Shamil R Sunyaev; Cathy C Laurie; Xiaofeng Zhu; Richa Saxena; Xihong Lin; Susan Redline
Journal:  PLoS Genet       Date:  2019-04-16       Impact factor: 5.917

7.  Prevalence and impact of comorbid obstructive sleep apnoea in diffuse parenchymal lung diseases.

Authors:  Diandian Li; Bo Wang; Yi Liu; Haohua Wang
Journal:  PLoS One       Date:  2021-02-11       Impact factor: 3.240

Review 8.  Molecular biomarkers in interstitial lung diseases.

Authors:  Angelo De Lauretis; Elisabetta A Renzoni
Journal:  Mol Diagn Ther       Date:  2014-10       Impact factor: 4.074

Review 9.  Comorbidities and Complications in Idiopathic Pulmonary Fibrosis.

Authors:  Esteban Cano-Jiménez; Fernanda Hernández González; Guadalupe Bermudo Peloche
Journal:  Med Sci (Basel)       Date:  2018-08-30

Review 10.  Oxygen therapy in COPD and interstitial lung disease: navigating the knowns and unknowns.

Authors:  Yet H Khor; Elisabetta A Renzoni; Dina Visca; Christine F McDonald; Nicole S L Goh
Journal:  ERJ Open Res       Date:  2019-09-16
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.